<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT03270449</url>
  </required_header>
  <id_info>
    <org_study_id>H17-01782</org_study_id>
    <nct_id>NCT03270449</nct_id>
  </id_info>
  <brief_title>Community-based Intervention for Fibromyalgia: A Pilot Trial</brief_title>
  <official_title>A Multi-disciplinary, Community-based Group Intervention for Fibromyalgia: A Pilot Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Rheumatology Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Interior Health</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fibromyalgia (FM) is a multi-factorial chronic pain condition characterized by fluctuating&#xD;
      and heterogeneous symptoms. This leads to both reduced patient function and quality of life&#xD;
      and consequentially, significant economic burden on the society. Although numerous&#xD;
      pharmaceutical and multi-treatment approaches exist, there is lack of an integrated&#xD;
      multidisciplinary model of care for these patients. Such a system is hypothesized to be&#xD;
      beneficial for the patients and would help them regain function and significantly improve&#xD;
      their quality of life. The primary aim of this pilot clinical trial is to evaluate the&#xD;
      effectiveness of an integrated community-based multidisciplinary model of care for FM&#xD;
      patients in Penticton and surrounding areas. The comprehensive 10 week intervention will&#xD;
      provide care from a team of health care providers (psychiatrist, physiotherapist, certified&#xD;
      exercise therapist, dietitian, rheumatologist, and mental health clinician). Patients will&#xD;
      also attend a peer led pain self-management support group provided by the Arthritis Society.&#xD;
      The study aims at educating these patients about self-management of their symptoms such as&#xD;
      chronic pain, weight, sleep and mood disorders. The integration of health care between the&#xD;
      different providers will be achieved by &quot;huddle&quot; sessions that will be conducted on a monthly&#xD;
      basis. The evaluation of the study outcomes will be based on the RE-AIM framework. Data will&#xD;
      be collected through patient questionnaires, healthcare utilization data, and interviews with&#xD;
      providers. Data analysis will involve thematic analysis of qualitative data and statistical&#xD;
      methods for quantitative data.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 15, 2017</start_date>
  <completion_date type="Actual">June 30, 2019</completion_date>
  <primary_completion_date type="Actual">June 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient-perceived quality of care</measure>
    <time_frame>Change from baseline in perceived quality of care at 10 weeks and 6 months</time_frame>
    <description>Patient assessment of care received as measured by the Patient Assessment of Chronic Illness Care Questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Daily function #1</measure>
    <time_frame>Change from baseline in daily function at 10 weeks and 6 months</time_frame>
    <description>Physical disease and mental health related functioning as measured by Revised-Fibromyalgia Impact Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily function #2</measure>
    <time_frame>Change from baseline in daily function at 10 weeks and 6 months</time_frame>
    <description>Mental health related functioning as measured by Hospital Anxiety and Depression scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health care utilization (physician visits)</measure>
    <time_frame>Change from baseline in physician visits at 6 months</time_frame>
    <description>Number of physician visits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health care utilization (emergency visits)</measure>
    <time_frame>Change from baseline in emergency department visits at 6 months</time_frame>
    <description>Number of emergency department visits</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Sleep quality</measure>
    <time_frame>Change from baseline in sleep quality at 10 weeks</time_frame>
    <description>Quality of sleep as measured by Sleep scale - medical outcome scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Sleep quality</measure>
    <time_frame>Change from baseline in sleep quality at 6 months</time_frame>
    <description>Quality of sleep as measured by Sleep scale - medical outcome scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Attitudes of pain</measure>
    <time_frame>Change from baseline in pain attitudes at 10 weeks and 6 months</time_frame>
    <description>Measurement of pain through Survey of brief attitudes of pain</description>
  </other_outcome>
  <other_outcome>
    <measure>Irritability</measure>
    <time_frame>Change from baseline in irritability at 10 weeks</time_frame>
    <description>Irritability measured by Brief Irritability Test (BITe) questionnaire</description>
  </other_outcome>
  <other_outcome>
    <measure>Irritability</measure>
    <time_frame>Change from baseline in irritability at 6 months</time_frame>
    <description>Irritability measured by Brief Irritability Test (BITe) questionnaire</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient perspectives on self-management resources</measure>
    <time_frame>10 weeks</time_frame>
    <description>Questionnaire to be administered to gather patient perspectives on self-management resources offered via hard copy, online, and social media</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient perspectives on self-management resources</measure>
    <time_frame>6 months</time_frame>
    <description>Questionnaire to be administered to gather patient perspectives on self-management resources offered via hard copy, online, and social media</description>
  </other_outcome>
  <other_outcome>
    <measure>Provider perspectives on quality of care</measure>
    <time_frame>18 months</time_frame>
    <description>Interviews will be conducted to gather providers' perspectives on the model of care</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">84</enrollment>
  <condition>Fibromyalgia</condition>
  <arm_group>
    <arm_group_label>Multidisciplinary intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The 10-week intervention will include twice weekly 1-2 hours sessions with multiple professional team members to undergo education and exercise sessions. The multidisciplinary team will consist of a rheumatologist, rheumatology nurse, dietitian, physiotherapist, a trained exercise therapist, a physiologist who specializes in pain management, a psychiatrist and a mental health clinician. All intervention team members have expertise in working with individuals with chronic pain conditions. General disease information, current best practices and techniques such as self-pain management, pacing, sleep hygiene, approach to a healthy lifestyle and weight loss will be discussed. The total number of hours for the 10 week intervention is 31 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual care involves being referred to the local rheumatologist involved in the study. The rheumatologist and the rheumatology nurse will see the control group patients during a one hour one on one consultation appointment. During that time the patient's history will be taken, physical exam performed and investigations analyzed. If a diagnosis of fibromyalgia is confirmed, the rheumatologist and nurse will counsel the patient and provide resources for self directed management. Unless there is a concern of an alternative diagnosis, follow up will not be arranged.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Multidisciplinary intervention</intervention_name>
    <description>10 week multidisciplinary education and exercise</description>
    <arm_group_label>Multidisciplinary intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  formal diagnosis of FM&#xD;
&#xD;
          -  resident of Penticton or surrounding area&#xD;
&#xD;
          -  adults, aged 19 and older&#xD;
&#xD;
          -  fluent in English or bring a family member/friend to assist with translation&#xD;
&#xD;
          -  capacity to provide informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with a severe and/or chronic medical or psychiatric condition that would&#xD;
             impact ability to participate in the intervention&#xD;
&#xD;
          -  patients who are pregnant or lactating&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michelle Teo</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Balfour Medical Centre</name>
      <address>
        <city>Penticton</city>
        <state>British Columbia</state>
        <zip>V2A 4Z1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Fitzcharles MA, Ste-Marie PA, Goldenberg DL, Pereira JX, Abbey S, Choiniere M, Ko G, Moulin DE, Panopalis P, Proulx J, Shir Y; National Fibromyalgia Guideline Advisory Panel. 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Res Manag. 2013 May-Jun;18(3):119-26. doi: 10.1155/2013/918216.</citation>
    <PMID>23748251</PMID>
  </reference>
  <reference>
    <citation>Schaefer C, Chandran A, Hufstader M, Baik R, McNett M, Goldenberg D, Gerwin R, Zlateva G. The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States. Health Qual Life Outcomes. 2011 Aug 22;9:71. doi: 10.1186/1477-7525-9-71.</citation>
    <PMID>21859448</PMID>
  </reference>
  <reference>
    <citation>Lachaine J, Beauchemin C, Landry PA. Clinical and economic characteristics of patients with fibromyalgia syndrome. Clin J Pain. 2010 May;26(4):284-90. doi: 10.1097/AJP.0b013e3181cf599f.</citation>
    <PMID>20393262</PMID>
  </reference>
  <reference>
    <citation>Thompson JM, Luedtke CA, Oh TH, Shah ND, Long KH, King S, Branda M, Swanson R. Direct medical costs in patients with fibromyalgia: Cost of illness and impact of a brief multidisciplinary treatment program. Am J Phys Med Rehabil. 2011 Jan;90(1):40-6. doi: 10.1097/PHM.0b013e3181fc7ff3.</citation>
    <PMID>20975520</PMID>
  </reference>
  <reference>
    <citation>Winkelmann A, Perrot S, Schaefer C, Ryan K, Chandran A, Sadosky A, Zlateva G. Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study. Appl Health Econ Health Policy. 2011 Mar 1;9(2):125-36. doi: 10.2165/11535250-000000000-00000.</citation>
    <PMID>21332254</PMID>
  </reference>
  <reference>
    <citation>Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE, Blonna D. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat. 2012;2012:426130. doi: 10.1155/2012/426130. Epub 2012 Nov 4. Erratum In: Pain Res Treat. 2013;2013:960270.</citation>
    <PMID>23213512</PMID>
  </reference>
  <reference>
    <citation>Gaglio B, Shoup JA, Glasgow RE. The RE-AIM framework: a systematic review of use over time. Am J Public Health. 2013 Jun;103(6):e38-46. doi: 10.2105/AJPH.2013.301299. Epub 2013 Apr 18.</citation>
    <PMID>23597377</PMID>
  </reference>
  <reference>
    <citation>Richards L, Morse J. Read me first for a users guide to qualitative methods. (3rd ed.) Sage Publications, Inc. 2013.</citation>
  </reference>
  <reference>
    <citation>Verbeke G, Molenberghs G. Linear mixed models for longitudinal data. Springer Science &amp; Business Media; 2009.</citation>
  </reference>
  <reference>
    <citation>Glasgow RE, Wagner EH, Schaefer J, Mahoney LD, Reid RJ, Greene SM. Development and validation of the Patient Assessment of Chronic Illness Care (PACIC). Med Care. 2005 May;43(5):436-44. doi: 10.1097/01.mlr.0000160375.47920.8c.</citation>
    <PMID>15838407</PMID>
  </reference>
  <reference>
    <citation>Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009;11(4):R120. doi: 10.1186/ar2783. Epub 2009 Aug 10. Erratum In: Arthritis Res Ther. 2009;11(5):415.</citation>
    <PMID>19664287</PMID>
  </reference>
  <reference>
    <citation>Nam S, Tin D, Bain L, Thorne JC, Ginsburg L. Clinical utility of the Hospital Anxiety and Depression Scale (HADS) for an outpatient fibromyalgia education program. Clin Rheumatol. 2014 May;33(5):685-92. doi: 10.1007/s10067-013-2377-1. Epub 2013 Sep 1.</citation>
    <PMID>23995734</PMID>
  </reference>
  <reference>
    <citation>Cappelleri JC, Bushmakin AG, McDermott AM, Dukes E, Sadosky A, Petrie CD, Martin S. Measurement properties of the Medical Outcomes Study Sleep Scale in patients with fibromyalgia. Sleep Med. 2009 Aug;10(7):766-70. doi: 10.1016/j.sleep.2008.09.004. Epub 2009 Jan 29.</citation>
    <PMID>19185539</PMID>
  </reference>
  <reference>
    <citation>Tait RC, Chibnall JT. Development of a brief version of the Survey of Pain Attitudes. Pain. 1997 Apr;70(2-3):229-35. doi: 10.1016/s0304-3959(97)03330-7.</citation>
    <PMID>9150298</PMID>
  </reference>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>August 21, 2017</study_first_submitted>
  <study_first_submitted_qc>August 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 1, 2017</study_first_posted>
  <last_update_submitted>October 7, 2019</last_update_submitted>
  <last_update_submitted_qc>October 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of British Columbia</investigator_affiliation>
    <investigator_full_name>Nelly Oelke</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>fibromyalgia</keyword>
  <keyword>community-based</keyword>
  <keyword>multidisciplinary</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT03270449
org study id: H17-01782
nct id: NCT03270449
lead sponsor: 
collaborator: 
collaborator: 
is fda regulated drug: No
is fda regulated device: No
Fibromyalgia (FM) is a multi-factorial chronic pain condition characterized by fluctuating
      and heterogeneous symptoms. This leads to both reduced patient function and quality of life
      and consequentially, significant economic burden on the society. Although numerous
      pharmaceutical and multi-treatment approaches exist, there is lack of an integrated
      multidisciplinary model of care for these patients. Such a system is hypothesized to be
      beneficial for the patients and would help them regain function and significantly improve
      their quality of life. The primary aim of this pilot clinical trial is to evaluate the
      effectiveness of an integrated community-based multidisciplinary model of care for FM
      patients in Penticton and surrounding areas. The comprehensive 10 week intervention will
      provide care from a team of health care providers (psychiatrist, physiotherapist, certified
      exercise therapist, dietitian, rheumatologist, and mental health clinician). Patients will
      also attend a peer led pain self-management support group provided by the Arthritis Society.
      The study aims at educating these patients about self-management of their symptoms such as
      chronic pain, weight, sleep and mood disorders. The integration of health care between the
      different providers will be achieved by "huddle" sessions that will be conducted on a monthly
      basis. The evaluation of the study outcomes will be based on the RE-AIM framework. Data will
      be collected through patient questionnaires, healthcare utilization data, and interviews with
      providers. Data analysis will involve thematic analysis of qualitative data and statistical
      methods for quantitative data.
allocation: Randomized
intervention model: Parallel Assignment
primary purpose: Health Services Research
masking: None (Open Label)
measure: Patient-perceived quality of care
time frame: Change from baseline in perceived quality of care at 10 weeks and 6 months
description: Patient assessment of care received as measured by the Patient Assessment of Chronic Illness Care Questionnaire
measure: Daily function #1
time frame: Change from baseline in daily function at 10 weeks and 6 months
description: Physical disease and mental health related functioning as measured by Revised-Fibromyalgia Impact Questionnaire
measure: Daily function #2
time frame: Change from baseline in daily function at 10 weeks and 6 months
description: Mental health related functioning as measured by Hospital Anxiety and Depression scale
measure: Health care utilization (physician visits)
time frame: Change from baseline in physician visits at 6 months
description: Number of physician visits
measure: Health care utilization (emergency visits)
time frame: Change from baseline in emergency department visits at 6 months
description: Number of emergency department visits
measure: Sleep quality
time frame: Change from baseline in sleep quality at 10 weeks
description: Quality of sleep as measured by Sleep scale - medical outcome scale
measure: Sleep quality
time frame: Change from baseline in sleep quality at 6 months
description: Quality of sleep as measured by Sleep scale - medical outcome scale
measure: Attitudes of pain
time frame: Change from baseline in pain attitudes at 10 weeks and 6 months
description: Measurement of pain through Survey of brief attitudes of pain
measure: Irritability
time frame: Change from baseline in irritability at 10 weeks
description: Irritability measured by Brief Irritability Test (BITe) questionnaire
measure: Irritability
time frame: Change from baseline in irritability at 6 months
description: Irritability measured by Brief Irritability Test (BITe) questionnaire
measure: Patient perspectives on self-management resources
time frame: 10 weeks
description: Questionnaire to be administered to gather patient perspectives on self-management resources offered via hard copy, online, and social media
measure: Patient perspectives on self-management resources
time frame: 6 months
description: Questionnaire to be administered to gather patient perspectives on self-management resources offered via hard copy, online, and social media
measure: Provider perspectives on quality of care
time frame: 18 months
description: Interviews will be conducted to gather providers' perspectives on the model of care
arm group label: Multidisciplinary intervention
arm group type: Experimental
description: The 10-week intervention will include twice weekly 1-2 hours sessions with multiple professional team members to undergo education and exercise sessions. The multidisciplinary team will consist of a rheumatologist, rheumatology nurse, dietitian, physiotherapist, a trained exercise therapist, a physiologist who specializes in pain management, a psychiatrist and a mental health clinician. All intervention team members have expertise in working with individuals with chronic pain conditions. General disease information, current best practices and techniques such as self-pain management, pacing, sleep hygiene, approach to a healthy lifestyle and weight loss will be discussed. The total number of hours for the 10 week intervention is 31 hours.
arm group label: Usual care
arm group type: No Intervention
description: Usual care involves being referred to the local rheumatologist involved in the study. The rheumatologist and the rheumatology nurse will see the control group patients during a one hour one on one consultation appointment. During that time the patient's history will be taken, physical exam performed and investigations analyzed. If a diagnosis of fibromyalgia is confirmed, the rheumatologist and nurse will counsel the patient and provide resources for self directed management. Unless there is a concern of an alternative diagnosis, follow up will not be arranged.
intervention type: Other
intervention name: Multidisciplinary intervention
description: 10 week multidisciplinary education and exercise
arm group label: Multidisciplinary intervention
criteria: 
gender: All
minimum age: 19 Years
maximum age: N/A
healthy volunteers: No
last name: Michelle Teo
role: Principal Investigator
affiliation: University of British Columbia
facility: 
country: Canada
citation: Fitzcharles MA, Ste-Marie PA, Goldenberg DL, Pereira JX, Abbey S, Choiniere M, Ko G, Moulin DE, Panopalis P, Proulx J, Shir Y; National Fibromyalgia Guideline Advisory Panel. 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Res Manag. 2013 May-Jun;18(3):119-26. doi: 10.1155/2013/918216.
PMID: 23748251
citation: Schaefer C, Chandran A, Hufstader M, Baik R, McNett M, Goldenberg D, Gerwin R, Zlateva G. The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States. Health Qual Life Outcomes. 2011 Aug 22;9:71. doi: 10.1186/1477-7525-9-71.
PMID: 21859448
citation: Lachaine J, Beauchemin C, Landry PA. Clinical and economic characteristics of patients with fibromyalgia syndrome. Clin J Pain. 2010 May;26(4):284-90. doi: 10.1097/AJP.0b013e3181cf599f.
PMID: 20393262
citation: Thompson JM, Luedtke CA, Oh TH, Shah ND, Long KH, King S, Branda M, Swanson R. Direct medical costs in patients with fibromyalgia: Cost of illness and impact of a brief multidisciplinary treatment program. Am J Phys Med Rehabil. 2011 Jan;90(1):40-6. doi: 10.1097/PHM.0b013e3181fc7ff3.
PMID: 20975520
citation: Winkelmann A, Perrot S, Schaefer C, Ryan K, Chandran A, Sadosky A, Zlateva G. Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study. Appl Health Econ Health Policy. 2011 Mar 1;9(2):125-36. doi: 10.2165/11535250-000000000-00000.
PMID: 21332254
citation: Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE, Blonna D. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat. 2012;2012:426130. doi: 10.1155/2012/426130. Epub 2012 Nov 4. Erratum In: Pain Res Treat. 2013;2013:960270.
PMID: 23213512
citation: Gaglio B, Shoup JA, Glasgow RE. The RE-AIM framework: a systematic review of use over time. Am J Public Health. 2013 Jun;103(6):e38-46. doi: 10.2105/AJPH.2013.301299. Epub 2013 Apr 18.
PMID: 23597377
citation: Richards L, Morse J. Read me first for a users guide to qualitative methods. (3rd ed.) Sage Publications, Inc. 2013.
citation: Verbeke G, Molenberghs G. Linear mixed models for longitudinal data. Springer Science & Business Media; 2009.
citation: Glasgow RE, Wagner EH, Schaefer J, Mahoney LD, Reid RJ, Greene SM. Development and validation of the Patient Assessment of Chronic Illness Care (PACIC). Med Care. 2005 May;43(5):436-44. doi: 10.1097/01.mlr.0000160375.47920.8c.
PMID: 15838407
citation: Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009;11(4):R120. doi: 10.1186/ar2783. Epub 2009 Aug 10. Erratum In: Arthritis Res Ther. 2009;11(5):415.
PMID: 19664287
citation: Nam S, Tin D, Bain L, Thorne JC, Ginsburg L. Clinical utility of the Hospital Anxiety and Depression Scale (HADS) for an outpatient fibromyalgia education program. Clin Rheumatol. 2014 May;33(5):685-92. doi: 10.1007/s10067-013-2377-1. Epub 2013 Sep 1.
PMID: 23995734
citation: Cappelleri JC, Bushmakin AG, McDermott AM, Dukes E, Sadosky A, Petrie CD, Martin S. Measurement properties of the Medical Outcomes Study Sleep Scale in patients with fibromyalgia. Sleep Med. 2009 Aug;10(7):766-70. doi: 10.1016/j.sleep.2008.09.004. Epub 2009 Jan 29.
PMID: 19185539
citation: Tait RC, Chibnall JT. Development of a brief version of the Survey of Pain Attitudes. Pain. 1997 Apr;70(2-3):229-35. doi: 10.1016/s0304-3959(97)03330-7.
PMID: 9150298
responsible party type: Principal Investigator
investigator affiliation: University of British Columbia
investigator full name: Nelly Oelke
investigator title: Assistant Professor
mesh term: Fibromyalgia
mesh term: Myofascial Pain Syndromes